| 发明名称 |
Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase |
| 摘要 |
Compounds of the substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acids, show below: wherein the variables are as defined herein, and pharmaceutical compositions thereof, are provided for use as inhibitors of with MEK kinase.
|
| 申请公布号 |
US7943626(B2) |
申请公布日期 |
2011.05.17 |
| 申请号 |
US20100652570 |
申请日期 |
2010.01.05 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
DONG QING;KALDOR STEPHEN W. |
| 分类号 |
A61K31/505 |
主分类号 |
A61K31/505 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
